Role of Lysophospholipid Metabolism in Chronic Myelogenous Leukemia Stem Cells by Kazuhito Naka

“…It is well known that mature chronic myelogenous leukemia (CML) cells proliferate in response to oncogenic BCR–ABL1-dependent signaling, but how CML stem cells are able to survive in an oncogene-independent manner and cause disease relapse has long been elusive. …”
Get full text

Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia by David N. Perdigoto, Sandra Lopes, Francisco Portela, Maria Augusta Cipriano, Luís Tomé

Subjects: Get full text

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy by Zhenshu Xu, Shundong Cang, Ting Yang, Delong Liu

“…Emerging evidence suggests that the three tyrosine kinase inhibitors currently approved for the treatment of patients with chronic myelogenous leukemia (CML) – imatinib, dasatinib, and nilotinib – have potential cardiotoxic effects. …”
Get full text

Management of chronic myelogenous leukemia with COVID-19 and hepatitis B by Tian Yu, Tian Yu, Weiming Li, Tao Yu

Subjects: “…chronic myelogenous leukemia…”
Get full text

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE by Mateja Grat, Joško Vučkovič

Subjects: “…chronic myelogenous leukemia…”
Get full text

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests by Mohammad Ali Mashhadi, Mahmoud Ali Kaykhaei, Mahdi Mohammadi, Mahdi Hashemi, Tahere Mohamadi Fatide

Subjects: “…Chronic myelogenous leukemia…”
Get full text

A case of chronic myelogenous leukemia cutis: A rare presentation by U S Kanade, S D Birare, P Gadgil, S Y Swami

Get full text

The role of Lyn kinase in the development of imatinib resistance in chronic myelogenous leukemia by Camillo Porta, Federica Tagliani

“…Imatinib mesylate, a small-molecule inhibitor of BCRABL tyrosine kinase activity, has emerged as the well-recognized standard of treatment for chronic myelogenous leukemia (CML). Indeed, both its efficacy, tolerability, as well as cost-effectiveness have been clearly proven...…”
Get full text

"Transformation of chronic myelogenous leukemia to Multiple Myeloma: A case report " by "Ghavamzadeh A, Alimoghaddam K, Mehdipour P, Sharifian R, Schwanitz G, Shamshiri AR "

“…Chronic myelogenous leukemia (CML) is a stem cell disorder sometimes associated with lymphoproliferative disorders. …”
Get full text

Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma by Haitham Hilal Al-Mahrouqi, Anuradha Ganesh, Abdulhakim Al-Rawas, Vikas Khetan, Sana Al-Zuhaibi

Subjects: Get full text

Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia by Leo Reap, DO, Lyle Goldman, MD

Subjects: Get full text

Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia by Ramachandran Krishna Chandran, Narayanan Geetha, Kunnathur Murugesan Sakthivel, Kunnathur Murugesan Sakthivel, Raveendran Suresh Kumar, Kumarapillai Mohanan Nair Jagathnath Krishna, Hariharan Sreedharan

Get full text

"Transformation of chronic myelogenous leukemia to Multiple Myeloma: A case report " by "Ghavamzadeh A, Alimoghaddam K, Mehdipour P, Sharifian R, Schwanitz G, Shamshiri AR "

“…Chronic myelogenous leukemia (CML) is a stem cell disorder sometimes associated with lymphoproliferative disorders. …”
Get full text

Sudden unilateral visual loss as an initial presentation of chronic myelogenous leukemia by Len V Hua, Salisa K Williams

“…Blood work up and cytological analyses confirmed the Philadelphia chromosome, which has been implicated in the development of chronic myelogenous leukemia (CML). Further testing confirmed a diagnosis of chronic phase CML. …”
Get full text

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. by Boultwood, J, Fidler, C, Shepherd, P, Watkins, F, Snowball, J, Haynes, S, Kusec, R, Gaiger, A, Littlewood, T, Peniket, A, Wainscoat, J

“…We studied telomere length in the peripheral blood leukocyte samples of a large group of patients with chronic myelogenous leukemia (CML) by Southern blot hybridization using the (TTAGGG)4 probe. …”

Personalized Immunotherapy Treatment Strategies for a Dynamical System of Chronic Myelogenous Leukemia by Paul A. Valle, Luis N. Coria, Corina Plata

“…This paper is devoted to exploring personalized applications of cellular immunotherapy as a control strategy for the treatment of chronic myelogenous leukemia described by a dynamical system of three first-order ordinary differential equations. …”
Get full text

Erythroid blast crisis in chronic myelogenous leukemia: Case report and review of literature by Rochelle Nagales Nagamos, Teresa Gentile, Neerja Vajpayee

“…Chronic myelogenous leukemia (CML) is a myeloproliferative disorder where over a period of time 15–20% of patients show blastic transformation with majority transforming into acute myeloid leukemia, most of which are of granulocytic lineage. …”
Get full text

Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations by Sweet K, Pinilla-Ibarz J, Zhang L

Get full text

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia by Kota Yoshifuji, Koji Sasaki

Subjects: “…chronic myelogenous leukemia…”
Get full text

Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib by Emole J, Talabi T, Pinilla-Ibarz J

Subjects: “…chronic myelogenous leukemia nilotinib tyrosine kinase inhibitor…”
Get full text